These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 11364329)
1. New principles of HIV-related medical care. Deeks SG Focus; 1997 Apr; 12(5):5-7. PubMed ID: 11364329 [TBL] [Abstract][Full Text] [Related]
2. New standard sheds little light on best regimens. AIDS Alert; 1997 Jun; 12(6):61-4. PubMed ID: 11364356 [TBL] [Abstract][Full Text] [Related]
3. Guidelines shed light on identifying failed regimens. AIDS Alert; 1997 Aug; 12(8):87-8. PubMed ID: 11364472 [TBL] [Abstract][Full Text] [Related]
4. Antiretrovirals for the heavily experienced patient: hefty plans to holidays. Martinez LJ Res Initiat Treat Action; 1999 Oct; 5(4):5-8. PubMed ID: 11366942 [TBL] [Abstract][Full Text] [Related]
5. Viral resistance: how it may affect treatment options. Biehler GV Body Posit; 1998 Jun; 11(6):42-3. PubMed ID: 11365610 [TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
7. HIV drug resistance and the other causes of treatment failure. Schouten JT STEP Perspect; 1997; 9(3):5-8. PubMed ID: 11364937 [TBL] [Abstract][Full Text] [Related]
8. New questions about therapy. Boston AIDS Writers Group. Surviv News (Atlanta Ga); 1998 May; ():19-20. PubMed ID: 11365366 [TBL] [Abstract][Full Text] [Related]
9. New guidelines for HIV treatment; resistance testing now recommended. AIDS Treat News; 2000 Feb; (No 337):5-6. PubMed ID: 11367208 [TBL] [Abstract][Full Text] [Related]
11. When to switch your drug combo. Gallant JE Posit Aware; 1998; 9(1):29. PubMed ID: 11364999 [TBL] [Abstract][Full Text] [Related]
12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy: coping with failure, planning for success. Gallant JE Posit Aware; 1998; 9(3):51-2, 55-7. PubMed ID: 11365489 [TBL] [Abstract][Full Text] [Related]
15. Strategic approaches to antiretroviral treatment. Havlir DV Top HIV Med; 2003; 11(4):145-9. PubMed ID: 12876333 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic options or antiretroviral anarchy? Mascolini M J Int Assoc Physicians AIDS Care; 1999 Jan; 5(1):10-30. PubMed ID: 11366158 [TBL] [Abstract][Full Text] [Related]
17. General strategies, not rigid rules. Project Inform. Posit Aware; 1996; 7(6):23-5. PubMed ID: 11363976 [TBL] [Abstract][Full Text] [Related]
18. Resistance testing debate: does it make the grade? Simmons P Res Initiat Treat Action; 1999 Oct; 5(4):9-12. PubMed ID: 11366943 [TBL] [Abstract][Full Text] [Related]
19. Patients should know principles behind new guidelines. AIDS Alert; 1997 Aug; 12(8):suppl 1-4. PubMed ID: 11364477 [TBL] [Abstract][Full Text] [Related]
20. Drug failure and HIV resistance create frustrating scenarios for clinicians. Murphy MJ Fac Notes (New Orleans La); 1998; 10(5):1-3. PubMed ID: 11365830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]